Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

NCT01370642 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: vaniprevir
DRUG: Placebo to vaniprevir
BIOLOGICAL: Peg-IFN
DRUG: ribavirin

Sponsor

Merck Sharp & Dohme LLC